The UK’s first operational distance medical cannabis pharmacy launches
The UK’s first operational distance medical cannabis pharmacy has now launched, dedicated to fulfilling medical cannabis prescriptions.
EMMAC Life Sciences Group, Europe’s leading independent cannabis...
CBD market on course to grow 400% in Europe alone
Over the next five years, the global CBD market is expected to accelerate to $23.6bn, according to Grand View Research and Europe's CBD market...
Applying data to address Europe’s burgeoning CBD market
The European CBD market remains immature, and little data has been available to CBD brands seeking to understand consumers, here New Frontier Data share...
CBD in Europe report: making the single market real
Pan-European Association, ACTIVE has launched its first English-speaking report: CBD in Europe — Making the Single Market Real.
The report is the second ACTIVE report,...
Over 99% of patients able to reduce symptoms using medical cannabis
Results from a survey of medical cannabis patients showed that over 99% of patients confirmed they have reduced symptoms using medical cannabis.
Compassionate Certification Centers,...
The evolution of the American cannabis industry in the last decade
The American cannabis industry squinted into daylight as it emerged into a billion-dollar industry coming from a black market background. Since then, it is...
Past and future: the growth of CBD medicine
Even in the last decade of the past millennium, CBD medicine was criminalised and banned in many countries. So, what caused such a drastic...
ProPharma: seven things to consider in medical cannabis development
ProPharma Group takes a look at medical cannabis regulation and compliance.
Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
B3 Labs responds to FSA CBD deadline announcement
Last week The Food Standards Agency (FSA) formally issued a definitive timeline for Novel Food applications setting a deadline for the 31 March 2021...
Cannabis and psychedelics: gatherings to accelerate plant-based medicine
The world's leading cannabis and psychedelic medicines scientists and researchers, investors, industry leaders and opinion makers will gather in Tel Aviv next month for...
Little Green Pharma trades on ASX and signs cannabis supply agreement
Little Green Pharma has begun trading on the Australian Stock Exchange under the symbol, LGP, and has signed a cannabis supply agreement.
The AUS $10m...
Global platform launched for pharmaceutical-grade cannabis extracts
Clever Leaves has announced that it has launched its direct-to-business sales platform, Clever Leaves 360, for pharmceutical-grade cannabis extract products.
Clever Leaves, a leading multi-national operator...
CannaBiz: Professor Michael Barnes on the medical cannabis supply chain
Professor Michael Barnes tells Medical Cannabis Network about the challenges facing the UK’s current medical cannabis landscape and the medical cannabis supply chain.
MCN attended...
CannaBiz: Hannah Deacon on the need for healthcare reform
Hannah Deacon, medical cannabis campaigner and Head of Patient Access at LYPHE Group, tells MCN about her continuing fight for healthcare reform on medical...
Cannabis and Parkinson’s: cannabis substitute for treating Parkinson’s
A drug that provides the benefits obtained from medicinal cannabis without the "high" or other side effects may help to unlock a new treatment...
The countdown to Europe Canna Expo in Dublin is on
Europe Canna Expo (ECE) kickstarts their 2020 event series in Dublin, Ireland on the 3-4 March.
Europe Canna Expo are elated to announce Mile High...
PURE5 R134a extraction vs CO2 for extraction of cannabis
In this article, George Stantchev, CEO of PURE5 extraction, talks us through the benefits of the PURE5 R134a extraction methods vs CO2 for extraction...
Crop17: estate agent Savills to help British farmers grow medical cannabis
Estate agent Savills is teaming up with medical cannabis sector specialists to help British farmers and landowners capitalise on opportunities by growing medical cannabis.
Savills...
Valens Company to export first international cannabis products to Australia
Valens GroWorks has announced its first international shipments of white label products to customers in Australia.
Based on the purchase orders received, the initial shipments...
Daily cannabis users with chronic pain less likely to use opioids
Recent research has highlighted how daily cannabis users are less likely to use opioids to manage their chronic pain.
Researchers from the BCCSU and University...
